| Income Statement |
| Total Revenue | 308.00M |
|
| Revenues (USD) | 308.00M |
| Cost of Revenue | 162.20M |
| Gross Profit | 145.80M |
| Operating Expenses | 161.90M |
| Research and Development Expense | 97.80M |
| Selling, General and Administrative Expense | 54.70M |
| Operating Income | -16.10M |
| Interest Expense | 19.00M |
| Income Tax Expense | 423.40M |
| Net Income | -447.40M |
| Net Income Common Stock | -447.40M |
| Net Income Common Stock (USD) | -447.40M |
| Consolidated Income | -447.40M |
| Earnings per Basic Share | -11.50 |
| Earnings per Basic Share (USD) | -11.50 |
| Earnings per Diluted Share | -11.50 |
| Earning Before Interest & Taxes (EBIT) | -5.00M |
| Earning Before Interest & Taxes (USD) | -5.00M |
| Weighted Average Shares | 38.90M |
| Weighted Average Shares Diluted | 38.90M |
| Balance Sheet |
| Cash and Equivalents | 442.50M |
| Cash and Equivalents (USD) | 442.50M |
| Trade and Non-Trade Receivables | 164.00M |
| Current Assets | 787.00M |
| Property, Plant & Equipment Net | 86.90M |
| Total Assets | 2.10B |
| Debt Current | 439.60M |
| Total Debt | 837.30M |
| Current Liabilities | 701.30M |
| Debt Non-Current | 397.70M |
| Total Liabilities | 1.17B |
| Accumulated Retained Earnings (Deficit) | 699.10M |
| Shareholders Equity | 929.50M |
| Shareholders Equity (USD) | 929.50M |
| Assets Non-Current | 1.32B |
| Total Debt (USD) | 837.30M |
| Goodwill and Intangible Assets | 1.06B |
| Inventory | 156.40M |
| Liabilities Non-Current | 471.20M |
| Trade and Non-Trade Payables | 82.60M |
| Tax Assets | 6.20M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 31.60M |
| Net Cash Flow from Financing | -17.60M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 38.10M |
| Capital Expenditure | -12.30M |
| Issuance (Purchase) of Equity Shares | -300.00K |
| Net Cash Flow from Investing | -12.30M |
| Net Cash Flow from Operations | 67.60M |
| Effect of Exchange Rate Changes on Cash | 400.00K |
| Share Based Compensation | 34.20M |